Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02626702 · ClinicalTrials.gov registry record
Immune Modulators and IVF
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- 500
- Enrollment target
NCT02626702: Clinical Trial study, sponsored by Weill Medical College of Cornell University.
NCT02626702 is a clinical trial that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02626702 was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- 500 participants
- Enrollment target
Study Summary
Exploring the immune mediators of early pregnancy prospectively may help to identify new early interventions that will increase the likelihood of success and help women make informed decisions regarding their pregnancies.
Interventions
- OTHER Observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2015-07-31 |
| Est. Completion | 2019-08-31 |
Why NCT02626702 stopped before completion
NCT02626702 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.
NCT02626702 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02626702 about?
NCT02626702 is a clinical study titled "Immune Modulators and IVF". Exploring the immune mediators of early pregnancy prospectively may help to identify new early interventions that will increase the likelihood of success and help women make informed decisions regarding their pregnancies.
What is the current status of trial NCT02626702?
This trial is currently terminated. The enrollment target is 500 participants. The study started on 2015-07-31. Estimated completion is 2019-08-31.
What interventions are being tested in trial NCT02626702?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT02626702?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI